Tiamson Inc is a Pain Management Center in Rancho Cucamonga, California. It is situated at 10570 Foothill Blvd Ste 220, Rancho Cucamonga and its contact number is 909-808-4888. The authorized person of Tiamson Inc is Shylee Baustista Tiamson
who is Authorized Office / Owner of the center and their contact number is 909-808-4888.
Tiamson Inc Center Definition to come...
Complete Center Profile:
Tiamson Inc Center speciality, address, contact phone number and fax are as below.
Patients can call on the below given phone number for appointment.
Officially authorized person to contact for any management issues or complaints of this Center are as below. Person's position and contact details are also mentioned below.
Name:
Shylee Baustista Tiamson
Position:
Authorized Office / Owner
Contact Number:
909-808-4888
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details for Tiamson Inc Center are as mentioned below.
NPI Number:
1124745161
NPI Enumeration Date:
20 Oct, 2022
NPI Last Update On:
08 Feb, 2023
Medical Licenses:
Organizations can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Tiamson Inc are as mentioned below.
Specialization
License Number
State
Status
Family
Primary
Pain Management
Secondary
Physical Therapy
Secondary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
Tiamson Inc 10570 Foothill Blvd Ste 220, Rancho Cucamonga, California
Zip:
91730-3876
Phone Number:
909-808-4888
Patients can reach Tiamson Inc at 10570 Foothill Blvd Ste 220, Rancho Cucamonga, California or can call to book an appointment on 909-808-4888. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 14 April, 2025.